RTK mutations and human syndromes - when good receptors turn bad

被引:128
作者
Robertson, SC [1 ]
Tynan, JA
Donoghue, DJ
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Genet Mol, La Jolla, CA 92093 USA
关键词
D O I
10.1016/S0168-9525(00)02021-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in receptor tyrosine kinases (RTKs) have been linked to an increasing number of inherited human disease syndromes, including dwarfism, craniosynostosis, heritable cancer susceptibility, venous malformation and Piebaldism. Both gain-of-function mutations resulting in constitutive receptor activation, and loss-of-function mutations resulting in nan-functional or dominant negative receptors, have been observed. This review summarizes RTK families that are involved in inherited syndromes, describes the molecular consequences of the disease mutations, and predicts that many novel mutations remain to be identified.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 73 条
[1]   GDNF family neurotrophic factor signaling: Four masters, one servant? [J].
Airaksinen, MS ;
Titievsky, A ;
Saarma, M .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1999, 13 (05) :313-325
[2]   Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand [J].
Anderson, J ;
Burns, HD ;
Enriquez-Harris, P ;
Wilkie, AOM ;
Heath, JK .
HUMAN MOLECULAR GENETICS, 1998, 7 (09) :1475-1483
[3]   THE TRK FAMILY OF NEUROTROPHIN RECEPTORS [J].
BARBACID, M .
JOURNAL OF NEUROBIOLOGY, 1994, 25 (11) :1386-1403
[4]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[5]   Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase [J].
Birchmeier, C ;
Gherardi, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :404-410
[6]   Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].
Cappellen, D ;
De Oliveira, C ;
Ricol, D ;
de Medina, SGD ;
Bourdin, J ;
Sastre-Garau, X ;
Chopin, D ;
Thiery, JP ;
Radvanyi, F .
NATURE GENETICS, 1999, 23 (01) :18-20
[7]   Molecular heterogeneity of RET loss of function in Hirschsprung's disease [J].
Carlomagno, F ;
DeVita, G ;
Berlingieri, MT ;
deFranciscis, V ;
Melillo, RM ;
Colantuoni, V ;
Kraus, MH ;
DiFiore, PP ;
Fusco, A ;
Santoro, M .
EMBO JOURNAL, 1996, 15 (11) :2717-2725
[8]   Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines [J].
Chappuis-Flament, S ;
Pasini, A ;
De Vita, G ;
Ségouffin-Cariou, C ;
Fusco, A ;
Attié, T ;
Lenoir, GM ;
Santoro, M ;
Billaud, M .
ONCOGENE, 1998, 17 (22) :2851-2861
[9]   Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 [J].
Chesi, M ;
Nardini, E ;
Brents, LA ;
Schrock, E ;
Ried, T ;
Kuehl, WM ;
Bergsagel, PL .
NATURE GENETICS, 1997, 16 (03) :260-264
[10]   MODULAR BINDING DOMAINS IN SIGNAL-TRANSDUCTION PROTEINS [J].
COHEN, GB ;
REN, RB ;
BALTIMORE, D .
CELL, 1995, 80 (02) :237-248